Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

  • Source: A Phase 3b Extension Study of Adjunctive ALKS 5461 in the Treatment of Refractory Major Depressive Disorder

تفاصيل العنوان

×
Report

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

  • Source: A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder

تفاصيل العنوان

×
Report

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

  • Source: A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Tolerability of Two Titration Schedules for ALKS 5461 for the Adjunctive Treatment of Major

تفاصيل العنوان

×
Report

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study

  • Source: A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-5 Study)

تفاصيل العنوان

×
Report

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study

  • Source: A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-4 Study)

تفاصيل العنوان

×
Report

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

  • Source: A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder (the FORWARD-3 Study)

تفاصيل العنوان

×
Report

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

  • Source: A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant

تفاصيل العنوان

×
Report

A Long-Term Safety Study of ALKS 5461

  • Source: A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an

تفاصيل العنوان

×
Report

ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD

  • Source: A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Tolerability of ALKS 33-BUP Administration in Subjects With Major Depressive

تفاصيل العنوان

×
  • 1-9 ل  9 نتائج ل ""AlkS""